JPS56133275A - 2((3-amino-2-hydroxypropoxy)-styryl)-isoxazole, manufacture and medicine containing same - Google Patents

2((3-amino-2-hydroxypropoxy)-styryl)-isoxazole, manufacture and medicine containing same

Info

Publication number
JPS56133275A
JPS56133275A JP2323781A JP2323781A JPS56133275A JP S56133275 A JPS56133275 A JP S56133275A JP 2323781 A JP2323781 A JP 2323781A JP 2323781 A JP2323781 A JP 2323781A JP S56133275 A JPS56133275 A JP S56133275A
Authority
JP
Japan
Prior art keywords
hydroxypropoxy
isoxazole
styryl
amino
manufacture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2323781A
Other languages
English (en)
Inventor
Shiyuretsukaa Rainaa
Furitsuker Furitsutsuufuriidaa
Furanke Aruburehito
Renke Deiitaa
Guriisu Yoozefu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BASF SE
Original Assignee
BASF SE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BASF SE filed Critical BASF SE
Publication of JPS56133275A publication Critical patent/JPS56133275A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/08—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/18—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6527—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07F9/653—Five-membered rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2323781A 1980-02-23 1981-02-20 2((3-amino-2-hydroxypropoxy)-styryl)-isoxazole, manufacture and medicine containing same Pending JPS56133275A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19803006809 DE3006809A1 (de) 1980-02-23 1980-02-23 2-((3-amino-2-hydroxy-propoxy)-styryl)-isoxazole, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen

Publications (1)

Publication Number Publication Date
JPS56133275A true JPS56133275A (en) 1981-10-19

Family

ID=6095373

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2323781A Pending JPS56133275A (en) 1980-02-23 1981-02-20 2((3-amino-2-hydroxypropoxy)-styryl)-isoxazole, manufacture and medicine containing same

Country Status (5)

Country Link
EP (1) EP0034754A1 (ja)
JP (1) JPS56133275A (ja)
DE (1) DE3006809A1 (ja)
DK (1) DK76881A (ja)
ZA (1) ZA811128B (ja)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3423429A1 (de) * 1984-06-26 1986-01-02 Beiersdorf Ag, 2000 Hamburg Substituierte phenoxyalkylaminopropanole, verfahren zu ihrer herstellung und ihre verwendung sowie diese verbindungen enthaltende zubereitungen
IE59813B1 (en) * 1986-05-09 1994-04-06 Warner Lambert Co Styryl pyrazoles, isoxazoles and analogs thereof having activity as 5-lipoxy-genase inhibitors and pharmaceutical compositions containing them
DE4126994A1 (de) * 1991-08-16 1993-02-18 Basf Ag (alpha)-arylacrylsaeurederivate, ihre herstellung und verwendung zur bekaempfung von schaedlingen und pilzen
WO1994022842A1 (en) 1993-03-29 1994-10-13 Basf Aktiengesellschaft 1-amino-3-phenoxy propane derivatives as modulators of multi-drug resistance

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE754405A (fr) * 1969-08-05 1971-02-04 Thomae Gmbh Dr K Nouveaux beta-aryl-2-aminoalcoxystyrenes

Also Published As

Publication number Publication date
DK76881A (da) 1981-08-24
DE3006809A1 (de) 1981-09-24
EP0034754A1 (de) 1981-09-02
ZA811128B (en) 1982-03-31

Similar Documents

Publication Publication Date Title
JPS5791921A (en) Medicine and manufacture
NZ192400A (en) 5-methylisoxazole-4-carboxylic acid-4-trifluoromethyl-anilide and pharmaceutical compositions containing it
JPS5750913A (en) Nifedipin-containing solid medicine and manufacture
JPS55115866A (en) Allicinncyclodextrin contained complex and medicine
IL61930A0 (en) 25-hydroxy-26,26,26,27,27,27-hexafluoroch-olecalciferol and derivatives thereof
JPS54135769A (en) Novel mercaptoimidazole derivative*its manufacture and pharmateutical medicine containing it and its application
JPS56147777A (en) Novel heterocyclic derivative, its manufacture and medicine containing it
JPS5517382A (en) Nnarylsulfonylpyrrole*its manufacture and medicine containing it
JPS57123173A (en) 3,4-b is-substituted 1,2,5-oxydiazole-2-oxide, manufacture and pharmaceutical blend containing same
DE3171558D1 (en) Powdered elastomers and process thereof
JPS5758682A (en) Thiazoline derivatives, manufacture and medicinal composition containing same
JPS56150088A (en) Pyrimidyl-quinazoline,its manufacture and pharmaceutical blend containing it
JPS56150027A (en) 2,3-dichloro-2-trifluoromethyl-1,1,1,3,4,4,5,5,5- nonafluoropentane and its manufacture
JPS56133275A (en) 2((3-amino-2-hydroxypropoxy)-styryl)-isoxazole, manufacture and medicine containing same
DE2966178D1 (en) Compounds of the muramyl-peptide type and medicines containing them
JPS57120526A (en) Medicine containing kallikrein and manufacture
JPS56139435A (en) 3,3-dimethyl-1-phenoxy-butan-2-ol and manufacture
JPS5533467A (en) 11phenyll11propanol derivative*its manufacture and medicine containing it
JPS56169699A (en) Halogenated steroid, its manufacture and medicine containing it
JPS57128671A (en) Fluoropyrrolidinone, manufacture and herbicide containing same
JPS5775975A (en) Heterocyclic derivative, manufacture and medicinal composition containing same
JPS5573679A (en) Pharmacologic medicine having center control and antiimentalldisorder effect
PH16940A (en) Substituted phenoxy-aminopropanol derivatives and medicaments thereof
JPS5728059A (en) Novel dihydropyridazinone, manufacture and medicine containing same
JPS54151992A (en) Alkoxycarbonyll33benzodiazepin novel derivatives*their manufacture and medicine containing them